SCOPUS 정보 검색 플랫폼

Cancer Epidemiology Biomarkers and Prevention

Volumn 10, Issue 10, 2001, Pages 1077-1082

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: A population-based case-control study

(12) Hsing, Ann W a Chokkalingam, Anand P a Chen, Chu b Dightman, Douglas A b Gao, Yu Tang c Deng, Jie c Cheng, Jiarong c Nguyen, Hanh T d Reichardt, Juergen K V d Sesterhenn, Isabell A e Mostofi, F Kash e Stanczyk, Frank Z f

a NATIONAL CANCER INSTITUTE (United States)

b Fred Hutchinson Cancer Research Center (United States)

c SHANGHAI CANCER INSTITUTE (China)

d UNIVERSITY OF SOUTHERN CALIFORNIA (United States)

e ARMED FORCES INSTITUTE OF PATHOLOGY (United States)

f UNIVERSITY OF SOUTHERN CALIFORNIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ANDROSTANEDIOL; STEROID 5ALPHA REDUCTASE; VALINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CODON; DINUCLEOTIDE REPEAT; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE;

ADULT; AGE DISTRIBUTION; AGED; BASE SEQUENCE; CASE-CONTROL STUDIES; CHOLESTENONE 5 ALPHA-REDUCTASE; CONFIDENCE INTERVALS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; ODDS RATIO; OXIDOREDUCTASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; PROBABILITY; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0034788128 PISSN: 10559965 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (108)

References (39)

1
- 0033959520
- Cancer statistics 2000
- (2000) CA Cancer J. Clin. , vol.50 , pp. 7-33
- Greenlee, R.T.¹ Murray, T.² Bolden, S.³ Wingo, P.A.⁴

2
- 0017720307
- Latent carcinoma of prostate at autopsy in seven areas
- The International Agency for Research on Cancer, Lyon, France
- (1977) Int. J. Cancer , vol.20 , pp. 680-688
- Breslow, N.¹ Chan, C.W.² Dhom, G.³ Drury, R.A.⁴ Franks, L.M.⁵ Gellei, B.⁶ Lee, Y.S.⁷ Lundberg, S.⁸ Sparke, B.⁹ Sternby, N.H.¹⁰ Tulinius, H.¹¹

3
- 0033991685
- International trends and patterns of prostate cancer incidence and mortality
- (2000) Int. J. Cancer , vol.85 , pp. 60-67
- Hsing, A.W.¹ Tsao, L.² Devesa, S.S.³

4
- 0034811710
- Hormones and prostate cancer: What's next?
- (2001) Epidemiol. Rev. , vol.23 , pp. 42-58
- Hsing, A.W.¹

5
- 0022259664
- Prostate cancer in a Sprague-Dawley rat
- (1985) Prostate , vol.6 , pp. 389-393
- Pollard, M.¹ Luckert, P.H.²

6
- 0029020560
- Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17β or diethylstilbestrol
- (1995) Carcinogenesis (Lond.) , vol.16 , pp. 1311-1317
- Bosland, M.C.¹ Ford, H.² Horton, L.³

7
- 0031917521
- PNU 157706, a novel dual type I and II 5α-reductase inhibitor
- (1998) J. Steroid Biochem. Mol. Biol. , vol.64 , pp. 179-186
- Di Salle, E.¹ Giudici, D.² Radice, A.³ Zaccheo, T.⁴ Ornati, G.⁵ Nesi, M.⁶ Panzeri, A.⁷ Delos, S.⁸ Martin, P.M.⁹

8
- 0026730788
- Molecular genetics of steroid 5α-reductase 2 deficiency
- (1992) J. Clin. Investig. , vol.90 , pp. 799-809
- Thigpen, A.E.¹ Davis, D.L.² Milatovich, A.³ Mendonca, B.B.⁴ Imperato-McGinley, J.⁵ Griffin, J.E.⁶ Francke, U.⁷ Wilson, J.D.⁸ Russell, D.W.⁹

9
- 0026787734
- Structure of human type II 5α-reductase gene
- (1992) Endocrinology , vol.131 , pp. 1571-1573
- Labrie, F.¹ Sugimoto, Y.² Luu-The, V.³ Simard, J.⁴ Lachance, Y.⁵ Bachvarov, D.⁶ Leblanc, G.⁷ Durocher, F.⁸ Paquet, N.⁹

10
- 12044259684
- The molecular genetics of steroid 5α-reductases
- (1994) Recent Prog. Horm. Res. , vol.49 , pp. 275-284
- Russell, D.W.¹ Berman, D.M.² Bryant, J.T.³ Cala, K.M.⁴ Davis, D.L.⁵ Landrum, C.P.⁶ Prihoda, J.S.⁷ Silver, R.I.⁸ Thigpen, A.E.⁹ Wigley, W.C.¹⁰

11
- 0033936410
- Biochemical and pharmacogenetic dissection of human steroid 5α-reductase type II
- (2000) Pharmacogenetics , vol.10 , pp. 407-413
- Makridakis, N.M.¹ Di Salle, E.² Reichardt, J.K.³

12
- 0032532090
- Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility
- (1998) Cancer Res. , vol.58 , pp. 4497-4504
- Ross, R.K.¹ Pike, M.C.² Coetzee, G.A.³ Reichardt, J.K.⁴ Yu, M.C.⁵ Feigelson, H.⁶ Stanczyk, F.Z.⁷ Kolonel, L.N.⁸ Henderson, B.E.⁹

13
- 0026553251
- 5α-reductase activity and risk of prostate cancer among Japanese and US white and black males
- (1992) Lancet , vol.339 , pp. 887-889
- Ross, R.K.¹ Bernstein, L.² Lobo, R.A.³ Shimizu, H.⁴ Stanczyk, F.Z.⁵ Pike, M.C.⁶ Henderson, B.E.⁷

14
- 0025882885
- Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects
- (1991) J. Clin. Endocrinol. Metab. , vol.72 , pp. 1242-1248
- Lookingbill, D.P.¹ Demers, L.M.² Wang, C.³ Leung, A.⁴ Rittmaster, R.S.⁵ Santen, R.J.⁶

15
- 0030938257
- A prevalent missense substitution that modulates activity of prostatic steroid 5α-reductase
- (1997) Cancer Res. , vol.57 , pp. 1020-1022
- Makridakis, N.¹ Ross, R.K.² Pike, M.C.³ Chang, L.⁴ Stanczyk, F.Z.⁵ Kolonel, L.N.⁶ Shi, C.Y.⁷ Yu, M.C.⁸ Henderson, B.E.⁹ Reichardt, J.K.¹⁰

16
- 0033581453
- Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA
- (1999) Lancet , vol.354 , pp. 975-978
- Makridakis, N.M.¹ Ross, R.K.² Pike, M.C.³ Crocitto, L.E.⁴ Kolonel, L.N.⁵ Pearce, C.L.⁶ Henderson, B.E.⁷ Reichardt, J.K.⁸

17
- 0029093031
- Genetic variability of the human SRD5A2 gene: Implications for prostate cancer risk
- (1995) Cancer Res. , vol.55 , pp. 3973-3975
- Reichardt, J.K.¹ Makridakis, N.² Henderson, B.E.³ Yu, M.C.⁴ Pike, M.C.⁵ Ross, R.K.⁶

18
- 0034654218
- Association of SRD5A2 genotype and pathological characteristics of prostate tumors
- (2000) Cancer Res. , vol.60 , pp. 1626-1630
- Jaffe, J.M.¹ Malkowicz, S.B.² Walker, A.H.³ MacBride, S.⁴ Peschel, R.⁵ Tomaszewski, J.⁶ Van Arsdalen, K.⁷ Wein, A.J.⁸ Rebbeck, T.R.⁹

19
- 0033233173
- The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer
- (1999) Cancer Res. , vol.59 , pp. 5878-5881
- Febbo, P.G.¹ Kantoff, P.W.² Platz, E.A.³ Casey, D.⁴ Batter, S.⁵ Giovannucci, E.⁶ Hennekens, C.H.⁷ Stampfer, M.J.⁸

20
- 0032846313
- Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
- (1999) Carcinogenesis (Lond.) , vol.20 , pp. 1727-1731
- Lunn, R.M.¹ Bell, D.A.² Mohler, J.L.³ Taylor, J.A.⁴

21
- 0035371666
- Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5α-reductase type II (SRD5A2) genes on prostate cancer risk among the Japanese population
- (2001) Int. J. Cancer , vol.92 , pp. 683-686
- Yamada, Y.¹ Watanabe, M.² Murata, M.³ Yamanaka, M.⁴ Kubota, Y.⁵ Ito, H.⁶ Katoh, T.⁷ Kawamura, J.⁸ Yatani, R.⁹ Shiraishi, T.¹⁰

22
- 0030974511
- A polymorphism of the 5α-reductase gene and its association with prostate cancer: A case-control analysis
- (1997) Cancer Epidemiol. Biomark. Prev. , vol.6 , pp. 189-192
- Kantoff, P.W.¹ Febbo, P.G.² Giovannucci, E.³ Krithivas, K.⁴ Dahl, D.M.⁵ Chang, G.⁶ Hennekens, C.H.⁷ Brown, M.⁸ Stampfer, M.J.⁹

23
- 0034525928
- Body size and prostate cancer: A population-based case-control study in China
- (2000) Cancer Epidemiol. Biomark. Prev. , vol.9 , pp. 1335-1341
- Hsing, A.W.¹ Deng, J.² Sesterhenn, I.A.³ Mostofi, F.K.⁴ Stanczyk, F.Z.⁵ Benichou, J.⁶ Xie, T.⁷ Gao, Y.T.⁸

24
- 0034665359
- Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: A population-based case-control study in China
- (2000) Cancer Res. , vol.60 , pp. 5111-5116
- Hsing, A.W.¹ Gao, Y.T.² Wu, G.³ Wang, X.⁴ Deng, J.⁵ Chen, Y.L.⁶ Sesterhenn, I.A.⁷ Mostofi, F.K.⁸ Benichou, J.⁹ Chang, C.¹⁰

25
- 0035897513
- Prostate cancer risk and serum levels of insulin and leptin: A population-based study
- (2001) J. Natl. Cancer Inst. (Bethesda) , vol.93 , pp. 783-789
- Hsing, A.W.¹ Chua, S.² Gao, Y.T.³ Gentzschein, E.⁴ Chang, L.⁵ Deng, J.⁶ Stanczyk, F.Z.⁷

26
- 0027269686
- Unusual length polymorphism in human steroid 5α-reductase type 2 gene (SRD5A2)
- (1993) Hum. Mol. Genet. , vol.2 , pp. 820
- Davis, D.L.¹ Russell, D.W.²

27
- 0001855628
- Serum gonadotropin, testosterone, estradiol, and estrone levels prior to and following bilateral vasectomy
- I. H. Lepow and R. Crozier (eds.), New York: Academic Press
- (1979) Vasectomy: Immunologic and Pathophysiologic Effects in Animals and Man , pp. 165-175
- Goebelsmann, U.¹ Bernstein, G.S.² Gale, J.A.³ Kletzky, O.A.⁴ Nakamura, R.M.⁵ Coulson, A.H.⁶ Korelitz, J.J.⁷

28
- 0021999084
- 5α-reductase activity in the genital skin of hirsute women
- (1985) J. Clin. Endocrinol. Metab. , vol.60 , pp. 349-355
- Serafini, P.¹ Ablan, F.² Lobo, R.A.³

29
- 0028869786
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women
- (1995) J. Clin. Endocrinol. Metab. , vol.80 , pp. 233-238
- Wong, I.L.¹ Morris, R.S.² Chang, L.³ Spahn, M.A.⁴ Stanczyk, F.Z.⁵ Lobo, R.A.⁶

30
- 0026585840
- A reevaluation of estrogen status in postmenopausal women who smoke
- (1992) Am. J. Obstet. Gynecol. , vol.166 , pp. 1444-1448
- Cassidenti, D.L.¹ Pike, M.C.² Vijod, A.G.³ Stanczyk, F.Z.⁴ Lobo, R.A.⁵

31
- 0000071822
- IARC Sci. Publ. No. 32. Lyon, France: IARC
- (1980) Statistical Methods in Cancer Research. Volume I - The Analysis of Case-control Studies , vol.1
- Breslow, N.E.¹ Day, N.E.²

32
- 0035156454
- V89L polymorphism of type-2, 5-α reductase enzyme gene predicts prostate cancer presence and progression
- (2001) Urology , vol.57 , pp. 199-204
- Nam, R.K.¹ Toi, A.² Vesprini, D.³ Ho, M.⁴ Chu, W.⁵ Harvie, S.⁶ Sweet, J.⁷ Trachtenberg, J.⁸ Jewett, M.A.⁹ Narod, S.A.¹⁰

33
- 0035732936
- The association between polymorphisms in the CYP17 and 5α-reductase (SRD5A2) genes and serum androgen concentrations in men
- (2001) Cancer Epidemiol. Biomark. Prev. , vol.10 , pp. 185-189
- Allen, N.E.¹ Forrest, M.S.² Key, T.J.³

34
- 0029932413
- Phenotypic classification of male pseudohermaphroditism due to steroid 5α-reductase 2 deficiency
- (1996) Am. J. Med. Genet. , vol.63 , pp. 223-230
- Sinnecker, G.H.¹ Hiort, O.² Dibbelt, L.³ Albers, N.⁴ Dorr, H.G.⁵ Hauss, H.⁶ Heinrich, U.⁷ Hemminghaus, M.⁸ Hoepffner, W.⁹ Holder, M.¹⁰ Schnabel, D.¹¹ Kruse, K.¹²

35
- 0028900073
- The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation
- (1995) Mol. Cell. Biol. , vol.15 , pp. 2219-2230
- Zubiaga, A.M.¹ Belasco, J.G.² Greenberg, M.E.³

36
- 0032862564
- Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5α-reductase during prostate cancer progression
- (1999) J. Urol. , vol.161 , pp. 1355-1358
- Akalu, A.¹ Dnajian, D.A.² Highshaw, R.A.³ Nichols, P.W.⁴ Reichardt, J.K.⁵

37
- 0032742707
- Prostate cancer associated with CYP17 genotype
- (1999) Pharmacogenetics , vol.9 , pp. 635-639
- Wadelius, M.¹ Andersson, A.O.² Johansson, J.E.³ Wadelius, C.⁴ Rane, E.⁵

38
- 0034667481
- Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect
- (2000) Cancer Res. , vol.60 , pp. 5710-5713
- Habuchi, T.¹ Liqing, Z.² Suzuki, T.³ Sasaki, R.⁴ Tsuchiya, N.⁵ Tachiki, H.⁶ Shimoda, N.⁷ Satoh, S.⁸ Sato, K.⁹ Kakehi, Y.¹⁰ Kamoto, T.¹¹ Ogawa, O.¹² Kato, T.¹³

39
- 0033565113
- GEN GEN: The genomic genetic analysis of androgen-metabolic genes and prostate cancer as a paradigm for the dissection of complex phenotypes
- (1999) Front Biosci. , vol.4 , pp. D596-D600
- Reichardt, J.K.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.